WFH/LinkedIn
Sep 12, 2025, 15:57
WFH and Armenia: A Transformative Partnership for Hemophilia Patients Since 2018
World Federation of Hemophilia (WFH) shared on LinkedIn:
”Years ago in Armenia, people with hemophilia relied on frozen plasma and cryoprecipitate—treatments that couldn’t meet their needs.
In 2018, with the support of the WFH, a new hemophilia treatment center was established in Yerevan, providing access to better care, training for doctors and nurses, and humanitarian aid.
Watch how this partnership is changing lives below and learn more”
More winner stories featured in Hemostasis Today.
-
Sep 12, 2025, 06:39Chokri Ben Lamine: Approach to Intra-Operative Bleeding in G6P Deficiency – Key Causes and Management
-
Sep 11, 2025, 15:42The True Price of Gene Therapy: Breaking Down Beqvez’s $3.5M Cost and What Really Drives It
-
Sep 11, 2025, 14:49Samantha Nelson Shares "The Beat" - World Thrombosis Day Just Added Newsletter to LinkedIn
-
Sep 11, 2025, 13:01Do Not Miss ISTH Fast Five! Pediatric and Neonatal Thrombosis & Hemostasis and Many More Webinars
-
Sep 11, 2025, 08:33Alfonso J. Tafur Shares VascuLearn’s Free Virtual Support Groups This Fall for Patients and Providers
-
Sep 12, 2025, 06:21Flora Peyvandi on Why Plasminogen Activation Is Not Required to Prevent Venous Thrombosis
-
Sep 12, 2025, 03:38Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
-
Sep 11, 2025, 15:03Rapid ADAMTS13 Assays: A Key Milestone in the 100 Years of Innvoation in TTP Diagnosis - Silvio Castagni
-
Sep 11, 2025, 14:25Thrombin Generation Assays to Assess COC-Associated Procoagulant Alterations
-
Sep 11, 2025, 13:55Transplantation-Mediated Alloimmune Thrombocytopenia: Mostafa Faisal Mohammed Saleh Presents a Rare Case
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 11, 2025, 15:27Postpartum Haemorrhage: In Kenya, More than 120 Mothers Die for Every 100,000 Live Births
-
Sep 11, 2025, 15:11Join the Global Effort: World Thrombosis Day Campaign for Healthcare and Community Organizations
-
Sep 11, 2025, 14:26José Antonio García Erce: Self-Sufficiency in Blood Products - Utopia or Reality?
-
Sep 11, 2025, 08:08Al-Ola A Abdallah on MGUS-Related Bleeding Disorders
-
Sep 10, 2025, 19:32Denis Brutus Oduor: Call for Altruism in Blood Donation in Nairobi
Sep 12, 2025, 16:11
Sep 12, 2025, 05:27